Sirio Pharma Cash Flow Reinvestment Rate
Sirio Pharma cash flow reinvestment rate. Sirio Pharma (300791) has a Cash Flow Reinvestment Rate of 0.78x as of June 2023, reinvesting CN¥79.56 Million (capex CN¥59.65 Million plus investments CN¥19.92 Million) from operating cash flow of CN¥101.61 Million. See how financially flexible is Sirio Pharma to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sirio Pharma (2017–2024)
Cash flow reinvestment rate of Sirio Pharma from 2017 to 2024. Historical reinvestment intensity for Sirio Pharma across 8 annual periods. Explore Sirio Pharma cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Sirio Pharma Cash Flow Reinvestment Rate by Year (2017–2024)
Sirio Pharma cash flow reinvestment rate by year from 2017 to 2024. Year-by-year capital reinvestment analysis for Sirio Pharma. For the full cash flow conversion analysis, see Sirio Pharma cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.31x | CN¥740.12 Million | CN¥566.97 Million | CN¥412.13 Million | ▼ -68.7% |
| 2023 | 4.17x | CN¥1.61 Billion | CN¥386.08 Million | CN¥451.70 Million | ▲ +90.5% |
| 2022 | 2.19x | CN¥973.69 Million | CN¥444.86 Million | CN¥293.69 Million | ▼ -2.0% |
| 2021 | 2.23x | CN¥762.68 Million | CN¥341.38 Million | CN¥524.68 Million | ▲ +72.8% |
| 2020 | 1.29x | CN¥413.14 Million | CN¥319.57 Million | CN¥223.14 Million | ▼ -49.8% |
| 2019 | 2.58x | CN¥596.90 Million | CN¥231.60 Million | CN¥166.90 Million | ▼ -29.4% |
| 2018 | 3.65x | CN¥669.32 Million | CN¥183.46 Million | CN¥239.32 Million | ▼ -69.5% |
| 2017 | 11.95x | CN¥589.82 Million | CN¥49.35 Million | CN¥159.82 Million | — |